Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases. The company is dedicated to educating ...
Joint AASLD/IDSA practice recommendations reflect new data on prevention, treatment, and surveillance of chronic hepatitis B, ...
Newborn hepatitis B virus vaccination rates in the U.S. decreased by over 10 percentage points in the last 2 years after ...
Read more about how a dive in HBV rates in infants in the USA has undone years of steady increase in vaccination uptake.
Thomas Jeffries does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
Chronic hepatitis B (CHB) is a long-term infection of the liver caused by the hepatitis B virus (HBV). While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the ...
By Nancy Lapid Feb 23 (Reuters) - Use of hepatitis B vaccines in U.S. newborns was declining well before the Centers for ...
Add Yahoo as a preferred source to see more of our stories on Google. About 80% of parents currently choose to follow CDC guidelines to vaccinate their babies for hepatitis B at birth.
At CROI 2026, experts warned that missing HBV screening risks reactivation during HIV therapy switches.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results